Akari Therapeutics Plc (AKTX)

0.2609 +0.01 (+2.31%) USD  |  NASDAQ  |  Feb 25, 16:00
0.2677 +0.01 (+2.61%) Pre-Market: 20:00
More

Akari Therapeutics Derivative Contract Liabilities (Quarterly)

Derivative Contract Liabilities (Quarterly) Chart

View Derivative Contract Liabilities (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Derivative Contract Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Derivative Contract Liabilities (Quarterly) Range, Past 5 Years

View Derivative Contract Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Derivative Contract Liabilities (Quarterly) Benchmarks

View Derivative Contract Liabilities (Quarterly) Benchmarks
Start Trial
DBV Technologies SA --
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --
NuCana Plc --
Autolus Therapeutics Plc --